Exclusive - Medivation discusses potential sale to Sanofi: sources

(Reuters) - U.S. drug cancer company Medivation Inc is discussing opening its books to Sanofi SA after the French drug company sweetened its $9.3 billion (£7.1 billion) acquisition offer, people familiar with the matter said on Tuesday.

from Reuters: Top News http://uk.reuters.com/article/uk-medivation-m-a-sanofi-fr-idUKKCN0ZL2D7?feedType=RSS&feedName=topNews